Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sight Sciences (SGHT) Non-cash Items (2020 - 2025)

Historic Non-cash Items for Sight Sciences (SGHT) over the last 6 years, with Q3 2025 value amounting to $1.7 million.

  • Sight Sciences' Non-cash Items fell 7465.69% to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 million, marking a year-over-year decrease of 7465.69%. This contributed to the annual value of $2.8 million for FY2024, which is 5325.79% down from last year.
  • Per Sight Sciences' latest filing, its Non-cash Items stood at $1.7 million for Q3 2025, which was down 7465.69% from $3.3 million recorded in Q2 2025.
  • In the past 5 years, Sight Sciences' Non-cash Items registered a high of $89.3 million during Q3 2021, and its lowest value of $1.0 million during Q1 2025.
  • For the 5-year period, Sight Sciences' Non-cash Items averaged around $17.4 million, with its median value being $7.7 million (2022).
  • Per our database at Business Quant, Sight Sciences' Non-cash Items soared by 21314.32% in 2021 and then tumbled by 9089.1% in 2022.
  • Sight Sciences' Non-cash Items (Quarter) stood at $58.4 million in 2021, then crashed by 66.68% to $19.5 million in 2022, then plummeted by 69.56% to $5.9 million in 2023, then plummeted by 53.26% to $2.8 million in 2024, then tumbled by 39.98% to $1.7 million in 2025.
  • Its Non-cash Items stands at $1.7 million for Q3 2025, versus $3.3 million for Q2 2025 and $1.0 million for Q1 2025.